做多
EOS Long-term | 530%+ Profits Potential to ATH

We are active trading EOS with the EOSU19 instrument, but the numbers there are equivalent to the EOSBTC pair, so you can use these numbers on this same chart...
EOSU19]8X]LONG]314.% ROE] High Risk, High Profits Lev. Trade
![[EOSU19][8X][LONG][314.% ROE] High Risk, High Profits Lev. Trade](https://s3.tradingview.com/s/S4DeO6V8_mid.png)
Now, let's take a look at EOS (EOSBTC) long-term.
EOSBTC can easily move higher, just take a look at this run:
We might be looking at something similar within just a few months.
Namaste.
EOSU19]8X]LONG]314.% ROE] High Risk, High Profits Lev. Trade
![[EOSU19][8X][LONG][314.% ROE] High Risk, High Profits Lev. Trade](https://s3.tradingview.com/s/S4DeO6V8_mid.png)
Now, let's take a look at EOS (EOSBTC) long-term.
- Notice that the early Dec. '17 support has been activated with a strong bounce following.
- The MACD is gaining momentum to the upside while showing strong bullish divergence from EOS price.
- The RSI is sitting now at 60.20, really bullish.
EOSBTC can easily move higher, just take a look at this run:
We might be looking at something similar within just a few months.
Namaste.
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
相关出版物
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
相关出版物
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。